Skip to content

Clinical trials

Phase 1/2 Small Cell Lung Carcinoma trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 1/2 Country / region: Poland Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20152
20211
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Completed2
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
BioNTech SE1
G1 Therapeutics, Inc.1
Gemin X1
MediLink Therapeutics (Suzhou) Co., Ltd.1
Merck Sharp & Dohme LLC1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma8
Carcinoma, Non-Small-Cell Lung2
Lung Diseases1
Melanoma1
Squamous Cell Carcinoma of Head and Neck1
Stomach Neoplasms1
Thoracic Neoplasms1
Triple Negative Breast Neoplasms1
Urinary Bladder Neoplasms1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.